Q: hi folks...opinion on Q3 results for Nutrien ntr/t...big reduction in earnings, yet stock closed positive.....Buy/Hold/Sell...thanks, jb
5i Research Answer:
NTR is now trading at 11.2x times' Forward P/E. In the 3Q, NTR’s revenue declined by -31% to $5.37B, missing estimates of $5.74B and EPS was $0.35 missing estimates of $0.65. The balance sheet has a net debt of $14.4B and a net debt/EBITDA is currently at 2.1x, okay for a cyclical name. NTR continues to return capital to shareholders through buybacks and dividends. The result was not strong, but given the strong market recently, it does help the share price to stabilize. Also, the expectations have gone down significantly, and comparison periods will get easier going forward. P/E is attractive at 11X.